Request for Information for a Review of the NIH HIV/AIDS Research Priorities and Guidelines for Determining AIDS Funding Document, 3476-3477 [2019-02027]

Download as PDF 3476 Federal Register / Vol. 84, No. 29 / Tuesday, February 12, 2019 / Notices Name of Committee: Center for Inherited Disease Research Access Committee. Date: March 1, 2019. Time: 11:30 a.m. to 1:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6700B Rockledge Drive, Room 3185, Bethesda, MD 20817, (Telephone Conference Call). Contact Person: Barbara J Thomas, Ph.D., Scientific Review Officer, Scientific Review Branch, National Human Genome Research Institute, National Institutes of Health, 5635 Fishers Lane, Ste. 4076, MSC 9306, Bethesda, MD 20892–9306, 301–402–0838, barbara.thomas@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human Genome Research, National Institutes of Health, HHS) Dated: February 6, 2019. Sylvia L. Neal, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2019–01966 Filed 2–11–19; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Nuclear and Cytoplasmic Structure Function Dynamics. Date: February 22, 2019. Time: 4:00 p.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Jessica Smith, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, jessica.smith6@nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. VerDate Sep<11>2014 18:30 Feb 11, 2019 Jkt 247001 (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: February 6, 2019. Ronald J. Livingston, Jr., Program Analyst, Office of Federal Advisory Committee Policy. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Request for Information for a Review of the NIH HIV/AIDS Research Priorities and Guidelines for Determining AIDS Funding Document AGENCY: [FR Doc. 2019–01965 Filed 2–11–19; 8:45 am] HHS. BILLING CODE 4140–01–P ACTION: National Institutes of Health, Notice. Through this Request for Information (RFI), the Office of AIDS Research (OAR) in the Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI), Office of the Director (OD), National Institutes of Health (NIH) invites feedback from interested stakeholders on a review of the NIH HIV/AIDS Research Priorities and Guidelines for Determining AIDS Funding (NOT–OD–15–137) now entering year four of implementation. The original Notice was released on August 12, 2015 to inform the scientific community of the overarching HIV/ AIDS research priorities and the guidelines used by NIH to determine HIV/AIDS funding beginning in fiscal year 2016 for the next three to five years. SUMMARY: DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Deafness and Other Communication Disorders; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Deafness and Other Communication Disorders Special Emphasis Panel, NIDCD Clinical Research Center Review. Date: March 14, 2019. Time: 10:00 a.m. to 2:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health Neuroscience Center Building, 6001 Executive Boulevard, Rockville, MD 20852 (Virtual Meeting). Contact Person: Katherine Shim, Ph.D., Scientific Review Officer Division of Extramural Activities, NIH/NIDCD, 6001 Executive Blvd., Room 8351, Bethesda, MD 20892, 301–496–8683, katherine.shim@ nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.173, Biological Research Related to Deafness and Communicative Disorders, National Institutes of Health, HHS) Dated: February 6, 2019. Sylvia L. Neal, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2019–01972 Filed 2–11–19; 8:45 am] BILLING CODE 4140–01–P PO 00000 Frm 00066 Fmt 4703 Sfmt 4703 After the public comment period has closed, all feedback received will be reviewed by the OAR and will be considered in the development of the next iteration of the NIH Research Priorities and Funding Guidance Document that will apply for the period of FY 2021 through FY 2025. ADDRESSES: Submissions may be electronically entered at (https:// grants.nih.gov/grants/rfi/rfi.cfm?ID=85). FOR FURTHER INFORMATION CONTACT: Questions about this request for information should be directed to Dr. Stacy Carrington-Lawrence, Office of AIDS Research, National Institutes of Health, Telephone: 301–496–3677, Email: OAR_Priorities_RFI@nih.gov, 5601 Fishers Lane Rockville, Maryland 20852. SUPPLEMENTARY INFORMATION: To respond this RFI, go to the following Web address. (https://grants.nih.gov/ grants/rfi/rfi.cfm?ID=85). As legislatively mandated, OAR plans and coordinates research through the development of an annual NIH Strategic Plan for HIV and HIV-Related Research that articulates the overarching HIV research priorities and serves as the framework for developing the overall NIH HIV research budget. OAR oversees and coordinates the conduct and support of all HIV research activities DATES: E:\FR\FM\12FEN1.SGM 12FEN1 Federal Register / Vol. 84, No. 29 / Tuesday, February 12, 2019 / Notices across the NIH Institutes and Centers (ICs). The NIH-sponsored HIV research programs include both extramural and intramural research, buildings and facilities, research training, program evaluation, and supports a comprehensive portfolio of research representing a broad range of basic, clinical, behavioral, social sciences, and translational research on HIV and its associated coinfections and comorbidities. The Plan provides information about the NIH’s HIV research priorities to the scientific community, Congress, community stakeholders, HIV-affected communities, and the broad public at large. The fiscal years 2019–2020 NIH Strategic Plan for HIV-Related Research was recently distributed and is available on the OAR website: (FY2019-2020 NIH Strategic Plan for HIV and HIV-Related Research). The current overarching priorities for HIV/AIDS research are defined in the NIH Director’s Statement of August 12, 2015 and Guide Notice NOT–OD–15– 137 (https://grants.nih.gov/grants/ guide/notice-files/NOT-OD-15137.html). High Priority topics of research for support include: (1) Reducing the incidence of HIV/ AIDS. (2) Developing the next generation of HIV therapies. (3) Identifying strategies towards a cure. (4) Improving the prevention and treatment of HIV-associated comorbidities, coinfections, and complications. (5) Cross-cutting areas that includes basic research, behavioral and social sciences research, health disparities, trainings, capacity-building and infrastructure. This RFI is for planning purposes only and should not be construed as a solicitation for applications or proposals, or as an obligation in any way on the part of the United States federal government. The federal government will not pay for the preparation of any information submitted or for the government’s use. Additionally, the government cannot guarantee the confidentiality of the information provided. Dated: February 4, 2019. Lawrence A. Tabak, Deputy Director, National Institutes of Health. [FR Doc. 2019–02027 Filed 2–11–19; 8:45 am] BILLING CODE 4140–01–P VerDate Sep<11>2014 18:30 Feb 11, 2019 Jkt 247001 DEPARTMENT OF HOMELAND SECURITY U.S. Customs and Border Protection [Docket No. USCBP–2018–0045] Announcing Change of Location for Public Meeting: 21st Century Customs Framework U.S. Customs and Border Protection (CBP), Department of Homeland Security (DHS). ACTION: Notice of change of location for public meeting. AGENCY: U.S. Customs and Border Protection (CBP) is announcing a change in location for ‘‘The 21st Century Customs Framework’’ public meeting to be held on Friday, March 1, 2019. The public meeting will be held at the U.S. Department of Commerce, Herbert Hoover Auditorium. CBP is also reopening the registration links to allow for additional participation. Participants who have previously registered do not need to re-register. DATES: Meeting: The meeting to discuss ‘‘The 21st Century Customs Framework’’ will be held on Friday, March 1, 2019, from 9:00 a.m. to 5:00 p.m. EST. Pre-registration: Members of the public wishing to attend the meeting whether in-person or via teleconference must register as indicated in the ADDRESSES section. Participants who have previously registered do not need to re-register. Registration will remain open until the venue reaches capacity. Cancellation of pre-registration: Members of the public who are preregistered to attend in-person or via teleconference and later need to cancel, please do so by 5:00 p.m. EST, February 22, 2019. ADDRESSES: Meeting: The meeting will be conducted in-person and via teleconference. The in-person meeting will be held at the U.S. Department of Commerce, Herbert Hoover Auditorium, 1401 Constitution Avenue NW, Washington, DC 20230. The teleconference number will be provided to all registrants by 5:00 p.m. EST on February 28, 2019. For information on services for individuals with disabilities or to request special assistance at the meeting, contact Mr. Brandon Lord, Office of Trade, U.S. Customs & Border Protection, at (202) 325–6432 or email, 21CCF@cbp.dhs.gov as soon as possible. Pre-registration: Meeting participants may attend either in-person or via teleconference after pre-registering using one of the methods indicated SUMMARY: PO 00000 Frm 00067 Fmt 4703 Sfmt 4703 3477 below. All in-person attendees must pre-register; on-site registration is not permitted. For members of the public who plan to attend the meeting in-person, please register online at https:// teregistration.cbp.gov/index.asp?w=145. For members of the public who plan to participate via teleconference, please register online at https:// teregistration.cbp.gov/index.asp?w=146. Participants who have previously registered do not need to re-register. Registration will remain open until the venue reaches capacity. Please feel free to share this information with other interested members of your organization or association. Members of the public who are preregistered to attend and later need to cancel, please do so by 5:00 p.m. EST, February 22, 2019, utilizing the following links: https:// teregistration.cbp.gov/cancel.asp?w=145 to cancel an in-person registration or https://teregistration.cbp.gov/ cancel.asp?w=146 to cancel a teleconference registration. Docket: For access to the docket or to read background documents or comments, go to https:// www.regulations.gov and search for Docket Number USCBP–2018–0045. FOR FURTHER INFORMATION CONTACT: Mr. Brandon Lord, Office of Trade, U.S. Customs and Border Protection, 1331 Pennsylvania Avenue NW, Suite 950N, Washington, DC 20229; telephone (202) 325–6432 or email 21CCF@cbp.dhs.gov. SUPPLEMENTARY INFORMATION: Change of Meeting Location On December 21, 2018, CBP published a notice in the Federal Register (83 FR 65703) announcing the ‘‘Public Meeting: 21st Century Customs Framework’’ initiative and public meeting. This document announces a change in location for the public meeting to be held on March 1, 2019. All other information, including times and topics to be addressed announced in the notice, remain the same. The inperson meeting will be held at the U.S. Department of Commerce, Herbert Hoover Auditorium, 1401 Constitution Avenue NW, Washington, DC 20230. Parking is available at the Ronald Reagan Building. The nearest metro stop is Federal Triangle. No food or drinks are allowed in the auditorium with the exception of bottled water. 21st Century Customs Framework Initiative Overview CBP is cognizant of the need to stay modern in order to meet the challenges of an evolving trade landscape. New E:\FR\FM\12FEN1.SGM 12FEN1

Agencies

[Federal Register Volume 84, Number 29 (Tuesday, February 12, 2019)]
[Notices]
[Pages 3476-3477]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-02027]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Request for Information for a Review of the NIH HIV/AIDS Research 
Priorities and Guidelines for Determining AIDS Funding Document

AGENCY: National Institutes of Health, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Through this Request for Information (RFI), the Office of AIDS 
Research (OAR) in the Division of Program Coordination, Planning, and 
Strategic Initiatives (DPCPSI), Office of the Director (OD), National 
Institutes of Health (NIH) invites feedback from interested 
stakeholders on a review of the NIH HIV/AIDS Research Priorities and 
Guidelines for Determining AIDS Funding (NOT-OD-15-137) now entering 
year four of implementation. The original Notice was released on August 
12, 2015 to inform the scientific community of the overarching HIV/AIDS 
research priorities and the guidelines used by NIH to determine HIV/
AIDS funding beginning in fiscal year 2016 for the next three to five 
years.

DATES: After the public comment period has closed, all feedback 
received will be reviewed by the OAR and will be considered in the 
development of the next iteration of the NIH Research Priorities and 
Funding Guidance Document that will apply for the period of FY 2021 
through FY 2025.

ADDRESSES: Submissions may be electronically entered at (https://grants.nih.gov/grants/rfi/rfi.cfm?ID=85).

FOR FURTHER INFORMATION CONTACT: Questions about this request for 
information should be directed to Dr. Stacy Carrington-Lawrence, Office 
of AIDS Research, National Institutes of Health, Telephone: 301-496-
3677, Email: OAR_Priorities_RFI@nih.gov, 5601 Fishers Lane Rockville, 
Maryland 20852.

SUPPLEMENTARY INFORMATION: To respond this RFI, go to the following Web 
address. (https://grants.nih.gov/grants/rfi/rfi.cfm?ID=85).
    As legislatively mandated, OAR plans and coordinates research 
through the development of an annual NIH Strategic Plan for HIV and 
HIV-Related Research that articulates the overarching HIV research 
priorities and serves as the framework for developing the overall NIH 
HIV research budget. OAR oversees and coordinates the conduct and 
support of all HIV research activities

[[Page 3477]]

across the NIH Institutes and Centers (ICs). The NIH-sponsored HIV 
research programs include both extramural and intramural research, 
buildings and facilities, research training, program evaluation, and 
supports a comprehensive portfolio of research representing a broad 
range of basic, clinical, behavioral, social sciences, and 
translational research on HIV and its associated coinfections and 
comorbidities.
    The Plan provides information about the NIH's HIV research 
priorities to the scientific community, Congress, community 
stakeholders, HIV-affected communities, and the broad public at large. 
The fiscal years 2019-2020 NIH Strategic Plan for HIV-Related Research 
was recently distributed and is available on the OAR website: (FY2019-
2020 NIH Strategic Plan for HIV and HIV-Related Research).
    The current overarching priorities for HIV/AIDS research are 
defined in the NIH Director's Statement of August 12, 2015 and Guide 
Notice NOT-OD-15-137 (https://grants.nih.gov/grants/guide/notice-files/NOT-OD-15-137.html).
    High Priority topics of research for support include:
    (1) Reducing the incidence of HIV/AIDS.
    (2) Developing the next generation of HIV therapies.
    (3) Identifying strategies towards a cure.
    (4) Improving the prevention and treatment of HIV-associated 
comorbidities, coinfections, and complications.
    (5) Cross-cutting areas that includes basic research, behavioral 
and social sciences research, health disparities, trainings, capacity-
building and infrastructure.
    This RFI is for planning purposes only and should not be construed 
as a solicitation for applications or proposals, or as an obligation in 
any way on the part of the United States federal government. The 
federal government will not pay for the preparation of any information 
submitted or for the government's use. Additionally, the government 
cannot guarantee the confidentiality of the information provided.

    Dated: February 4, 2019.
Lawrence A. Tabak,
Deputy Director, National Institutes of Health.
[FR Doc. 2019-02027 Filed 2-11-19; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.